SELLAS Life Sciences Group, Inc. (NASDAQ:SLS – Get Free Report) was the target of some unusual options trading activity on Monday. Traders bought 9,455 call options on the stock. This is an increase ...
Maxim Group analyst Jason McCarthy reiterated a Buy rating on SELLAS Life Sciences Group (SLS – Research Report) yesterday and set a price ...
The success of SpaceX and other private-sector space firms is throwing up hard questions about America's "great national ...
SELLAS Life Sciences Group, Inc.’s SLS share price has dipped by 17.02%, which has investors questioning if this is right ...
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel ...
Assembly of the Artemis II moon rocket has reached its latest milestone with the stacking of the twin boosters' right forward ...
1 Day SLS 35.15% DJIA 0.31% Russell 2K -0.66% Health ... Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results